Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00859729 | Dose Finding Study of a DNA Vaccine Delivered With Intradermal Electroporation in Patients With Prostate Cancer | completed | Phase 1 / Phase 2 | 15 | Uppsala UniversityOTHER | 1 | Mar 17, 2014 | clinicaltrials |
| NCT00890747 | Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy | completed | Phase 1 | 42 | National Cancer Institute (NCI)NIH | 1 | Mar 17, 2014 | clinicaltrials |
| NCT02088164 | Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese Men | completed | — | 27,741 | National Taiwan University HospitalOTHER | 1 | Mar 14, 2014 | clinicaltrials |
| NCT02086266 | The Efficacy of Pilates in the Recovery of Post-prostatectomy Urinary Incontinence | completed | N/A | 54 | Universidade Estadual de LondrinaOTHER | 0 | Mar 13, 2014 | clinicaltrials |
| NCT01100866 | Study of POMELLA™ Extract to Treat Prostate Cancer | terminated | N/A | 1 | Vancouver Coastal HealthOTHER_GOV | 1 | Mar 11, 2014 | clinicaltrials |
| NCT00770848 | AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer | completed | Phase 1 / Phase 2 | 162 | AmgenINDUSTRY | 0 | Mar 10, 2014 | clinicaltrials |
| NCT01338792 | Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer | completed | Phase 2 | 47 | University of Southern CaliforniaOTHER | 1 | Mar 10, 2014 | clinicaltrials |
| NCT00015977 | Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 2 | 13 | University of ChicagoOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00258284 | Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer | completed | Phase 2 | 30 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Mar 6, 2014 | clinicaltrials |
| NCT00078923 | Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate | completed | Phase 2 | 32 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Mar 5, 2014 | clinicaltrials |
| NCT01007214 | Guided Biopsy for Mapping Prostate Cancer(HIT) | terminated | N/A | 7 | Roswell Park Cancer InstituteOTHER | 1 | Feb 27, 2014 | clinicaltrials |
| NCT00887640 | Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer | terminated | Phase 2 | 11 | Duke UniversityOTHER | 1 | Feb 26, 2014 | clinicaltrials |
| NCT00004001 | S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 3 | 770 | SWOG Cancer Research NetworkNETWORK | 1 | Feb 25, 2014 | clinicaltrials |
| NCT02070952 | CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer | unknown | N/A | 167 | Riverside Community Hospital, CaliforniaOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT00458731 | Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma | completed | Phase 1 | 57 | National Cancer Institute (NCI)NIH | 1 | Feb 19, 2014 | clinicaltrials |
| NCT01734681 | Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | GenSpera, Inc.INDUSTRY | 1 | Feb 19, 2014 | clinicaltrials |
| NCT01176513 | GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate Cancer | terminated | Phase 2 | 25 | GE HealthcareINDUSTRY | 1 | Feb 14, 2014 | clinicaltrials |
| NCT01409473 | Stereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate Cancer(Prostate SBRT) | withdrawn | Phase 2 | 0 | Rocky Mountain Cancer CentersOTHER | 1 | Feb 12, 2014 | clinicaltrials |
| NCT00899665 | Proteases in Patients With Prostate Cancer That Has Spread to the Bone | completed | — | 31 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Feb 11, 2014 | clinicaltrials |
| NCT01715064 | Acute Effects of Exercise on the Cortical Silent Period in Prostate Cancer Patients | completed | Phase 2 / Phase 3 | 36 | University of Guelph-HumberOTHER | 1 | Feb 10, 2014 | clinicaltrials |
| NCT00295802 | Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer | unknown | Phase 2 / Phase 3 | 141 | EDAP TMS S.A.INDUSTRY | 2 | Feb 7, 2014 | clinicaltrials |
| NCT01250717 | Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer | completed | Phase 2 | 28 | Beth Israel Deaconess Medical CenterOTHER | 1 | Feb 4, 2014 | clinicaltrials |
| NCT00808418 | A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer | completed | Phase 1 | 34 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Feb 3, 2014 | clinicaltrials |
| NCT01495130 | Transrectal Ultrasound (TRUS) in Finding Tumors During Robotic-Assisted Laparoscopic Surgery | completed | N/A | 11 | University of Southern CaliforniaOTHER | 1 | Jan 29, 2014 | clinicaltrials |
| NCT00767286 | Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | completed | Phase 3 | — | Radiation Therapy Oncology GroupNETWORK | 0 | Jan 28, 2014 | clinicaltrials |
| NCT01764347 | Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Image-Guided Prostate Biopsy Following Radical Prostatectomy in Patients With Prostate Cancer | completed | N/A | 24 | University of Southern CaliforniaOTHER | 1 | Jan 28, 2014 | clinicaltrials |
| NCT00003312 | Brachytherapy in Treating Patients With Prostate Cancer | completed | Phase 2 | 95 | Radiation Therapy Oncology GroupNETWORK | 2 | Jan 24, 2014 | clinicaltrials |
| NCT00807820 | Phase I Targeting Dominant Intraprostatic Lesion Using MR Spectroscopy and HDR Brachytherapy | completed | — | 10 | University of California, San FranciscoOTHER | 1 | Jan 24, 2014 | clinicaltrials |
| NCT00479635 | A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer | terminated | Phase 2 | 26 | Cortice Biosciences, Inc.INDUSTRY | 1 | Jan 22, 2014 | clinicaltrials |
| NCT02041559 | The Effect of Different Doses of Remifentanil on Kidney Function During Robot Assisted Prostatectomy - A Retrospective Study | unknown | — | 1,500 | Yonsei UniversityOTHER | 1 | Jan 22, 2014 | clinicaltrials |
| NCT00706966 | MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer | completed | N/A | 10 | University of California, San FranciscoOTHER | 1 | Jan 17, 2014 | clinicaltrials |
| NCT02037464 | CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer(CAPSAICIN) | unknown | Phase 2 | 100 | Sunnybrook Health Sciences CentreOTHER | 1 | Jan 16, 2014 | clinicaltrials |
| NCT00305747 | Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy | completed | Phase 1 | 12 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Jan 15, 2014 | clinicaltrials |
| NCT00922129 | Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer | withdrawn | Phase 2 / Phase 3 | 0 | St. Joseph's Healthcare HamiltonOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT01793077 | Observational, Non-interventional, Non Comparative Real Life Data Collection of Depo-Eligard® 7.5 mg, 22.5 mg and 45 mg in Male Prostate Cancer Patients(TREMODI) | completed | — | 259 | Astellas Pharma Europe B.V.INDUSTRY | 1 | Jan 13, 2014 | clinicaltrials |
| NCT00398281 | Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer | completed | Phase 3 | 450 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00967954 | Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer | unknown | N/A | 120 | Cancer Research UKOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT01000948 | A Safety Study of ZD4054 in Prior Chemotherapy Treated Patients With Metastatic Hormone-resistant Prostate Cancer(DAPROCA-1) | terminated | Phase 2 | 24 | Aarhus University HospitalOTHER | 1 | Jan 8, 2014 | clinicaltrials |
| NCT00917865 | FACBC Positron Emission Tomography/Computed Tomography(PET/CT) Used in the Diagnosis of Primary Prostate Cancer | terminated | Phase 2 | 11 | David M. Schuster, MDOTHER | 1 | Jan 7, 2014 | clinicaltrials |
| NCT00002775 | Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 1 / Phase 2 | 37 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00003124 | Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer | completed | Phase 2 | 105 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT01174953 | High Risk Prostate Cancer Prevention Study | completed | N/A | 18 | University of KansasOTHER | 1 | Jan 1, 2014 | clinicaltrials |
| NCT01347320 | Preoperative Magnetic Resonance (MR) Imaging of Prostate Cancer | completed | N/A | 400 | Oslo University HospitalOTHER | 1 | Dec 30, 2013 | clinicaltrials |
| NCT01455792 | Biopsy Study Comparing MRI and Ultrasound Soft Image Fusion Guided Biopsies and Gold Standard Prostate Biopsies. | completed | N/A | 200 | Oslo University HospitalOTHER | 1 | Dec 30, 2013 | clinicaltrials |
| NCT02020876 | Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations(DECIDE) | completed | — | 21 | GenomeDx Biosciences CorpINDUSTRY | 1 | Dec 25, 2013 | clinicaltrials |
| NCT00003633 | Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer | unknown | Phase 1 | 12 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003717 | Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 2 | 17 | St. Barnabas Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00024063 | SU006668 in Treating Patients With Advanced Solid Tumors | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Dec 19, 2013 | clinicaltrials |
| NCT00433797 | Dietary Intervention With Phytochemicals and Polyunsaturated Fatty Acids in Prostate Cancer Patients | completed | Phase 1 / Phase 2 | 86 | University of OsloOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00045123 | R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence | unknown | Phase 2 | — | Myrexis Inc.INDUSTRY | 1 | Dec 18, 2013 | clinicaltrials |
Data updated 24 days agoSource updated Mar 17, 2014source: clinicaltrials